PURPL is associated with adverse clinical outcome in Luminal A breast cancer
Salvador Ochoa Zavalza, Maxime Pouokam, Masato Kruse, G. Montero González, Radmila Sazdanović, Javier Arsuaga
The paper identifies PURPL as a long non-coding RNA associated with poor clinical outcomes in Luminal A breast cancer through copy number, expression, and survival analyses across multiple cohorts.
bioRxiv · Nov 11, 2025 · PreprintCancer Biology